Genomic Alterations and Allelic Imbalances Are Strong Prognostic Predictors in Osteosarcoma

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical Cancer Research

• Publication date

  2010-07-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-10-0284PMID 20610556
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma.

  2010cited by this paper
• Molecular characterization of commonly used cell lines for bone tumor research: A trans‐European EuroBoNet effort

  2010cited by this paper
• Hepatocyte Growth Factor Reduces Susceptibility to an Irreversible Epidermal Growth Factor Receptor Inhibitor in EGFR-T790M Mutant Lung Cancer

  2010cited by this paper
• Identification of chromosomal aberrations associated with disease progression and a novel 3q13.31 deletion involving LSAMP gene in osteosarcoma.

  2009cited by this paper
• Aneuploidy involving chromosome 1 may be an early predictive marker of intestinal type gastric cancer.

  2009cited by this paper
• Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2

  2009cited by this paper
• Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification

  2008cited by this paper
• Prognostic Significance of αV Integrin and VEGF in Osteosarcoma after Chemotherapy

  2008cited by this paper
• Cell Cycle Regulator Gene CDC5L, a Potential Target for 6p12-p21 Amplicon in Osteosarcoma

  2008cited by this paper
• A review of clinical and molecular prognostic factors in osteosarcoma

  2008cited by this paper
• Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH

  2008cited by this paper
• Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors

  2008cited by this paper
• Osteosarcoma Development and Stem Cell Differentiation

  2008cited by this paper
• Aneuploidy in upper gastro-intestinal tract cancers--a potential prognostic marker?

  2008cited by this paper
• Patterns of somatic mutation in human cancer genomes

  2007cited by this paper
• Determination of the prognostic value of loss of heterozygosity at the retinoblastoma gene in osteosarcoma.

  2007cited by this paper
• Aneuploidy: instigator and inhibitor of tumorigenesis.

  2007cited by this paper
• Aneuploidy and cancer

  2007cited by this paper
• Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy

  2006cited by this paper
• Does aneuploidy cause cancer?

  2006cited by this paper
• Chromosome 6p amplification and cancer progression

  2006cited by this paper
• Expression profiles of osteosarcoma that can predict response to chemotherapy.

  2005cited by this paper
• Centrosome amplification, chromosome instability and cancer development.

  2005cited by this paper
• Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines

  2005cited by this paper
• Identification of CCND3 and BYSL as Candidate Targets for the 6p21 Amplification in Diffuse Large B-Cell Lymphoma

  2005cited by this paper
• Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma

  2004cited by this paper
• Frequent amplification and rearrangement of chromosomal bands 6p12‐p21 and 17p11.2 in osteosarcoma

  2004cited by this paper
• Morphological grades of regression in osteosarcoma after polychemotherapy — Study COSS 80

  2004cited by this paper
• Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas

  2003cited by this paper
• Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors.

  2003cited by this paper
• Chromosomal instability in osteosarcoma and its association with centrosome abnormalities.

  2003cited by this paper
• High‐resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays

  2003cited by this paper
• Genetic and Epigenetic Alterations of the Cell Cycle Regulators and Tumor Suppressor Genes in Pediatric Osteosarcomas

  2003cited by this paper
• Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumors

  2002cited by this paper
• Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas

  2002cited by this paper
• Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.

  2002cited by this paper
• Comparative genomic hybridization analysis identifies gains of 1p35 approximately p36 and chromosome 19 in osteosarcoma.

  2001cited by this paper
• Amplification and protein expression of chromosome 12q13-15 genes in osteosarcomas of the jaws.

  2001cited by this paper
• Cytogenetic Findings in 36 Osteosarcoma Specimens and a Review of the Literature

  2000cited by this paper
• Aneuploidy and cancer

  2000cited by this paper
• Alteration of pRb/p16/cdk4 regulation in human osteosarcoma

  1999cited by this paper
• Genetic instability of cancer cells is proportional to their degree of aneuploidy.

  1998cited by this paper
• C-myc and c-fos in Human Osteosarcoma: Prognostic Value of mRNA and Protein Expression

  1998cited by this paper
• Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature.

  1997cited by this paper
• Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas

  1996cited by this paper
• Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma.

  1996cited by this paper
• Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomas

  1995cited by this paper
• [Determination of the degree of morphological regression following chemotherapy in malignant bone tumors].

  1983cited by this paper

• Mouse Models of Osteosarcoma: Unraveling Disease Mechanisms and Accelerating Drug Discovery and Development

  2025cites this paper
• Non-Coding RNAs in Diagnostic Pathology of High-Grade Central Osteosarcoma

  2025cites this paper
• Ongoing chromothripsis underpins osteosarcoma genome complexity and clonal evolution.

  2025cites this paper
• Prognostic Value of the G2 Expression Signature and MYC Overexpression in Childhood High-Grade Osteosarcoma

  2025cites this paper
• Osteosarcoma through the Lens of Bone Development, Signaling, and Microenvironment.

  2024cites this paper
• Identification of XD23 as a potent inhibitor of osteosarcoma via downregulation of DKK1 and activation of the WNT/β-catenin pathway

  2024cites this paper
• Comprehensive genomic analysis of primary bone sarcomas reveals different genetic patterns compared with soft tissue sarcomas

  2023cites this paper
• Deciphering the Signaling Mechanisms of Osteosarcoma Tumorigenesis

  2023cites this paper
• Osteosarcoma in Pediatric and Adult Populations: Are Adults Just Big Kids?

  2023cites this paper
• WWOX promotes osteosarcoma development via upregulation of Myc

  2023cites this paper
• Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma

  2023cites this paper
• MYC regulates CSF1 expression via microRNA 17/20a to modulate tumor-associated macrophages in osteosarcoma

  2023cites this paper
• Sarcoma Common MHC-I Haplotype Restricts Tumor-Specific CD8+ T Cell Response

  2022cites this paper
• Cytogenetics of bone tumors

  2022cites this paper
• Origin and Therapies of Osteosarcoma

  2022cites this paper
• F-box only protein 9 and its role in cancer

  2022cites this paper
• Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report

  2021influential citation
• The Clinical Implications of Tumor Mutational Burden in Osteosarcoma

  2021cites this paper
• Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force

  2021cites this paper
• Novel fusion genes in spindle cell rhabdomyosarcoma: The spectrum broadens

  2021cites this paper
• Liquid Biopsies in Sarcoma Clinical Practice: Where Do We Stand?

  2021cites this paper
• NPR3, transcriptionally regulated by POU2F1, inhibits osteosarcoma cell growth through blocking the PI3K/AKT pathway.

  2021cites this paper
• Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for Osteosarcoma

  2020cites this paper
• Osteosarcoma: A comprehensive review of management and treatment strategies.

  2020cites this paper
• Is Use of BMP-2 Associated with Tumor Growth and Osteoblastic Differentiation in Murine Models of Osteosarcoma?

  2020cites this paper
• Osteosarcoma: A review with emphasis on pathogenesis and chemoresistance

  2020cites this paper
• Genomic Complexity of Osteosarcoma and Its Implication for Preclinical and Clinical Targeted Therapies.

  2020cites this paper
• Long Noncoding RNAs in Osteosarcoma: Mechanisms and Potential Clinical Implications

  2019cites this paper
• In-Vitro and In-Vivo Establishment and Characterization of Bioluminescent Orthotopic Chemotherapy-Resistant Human Osteosarcoma Models in NSG Mice

  2019cites this paper
• From 3D Cell Culture System to PersonalizedMedicine in Osteosarcoma

  2019cites this paper
• Prospects for the involvement of cancer stem cells in the pathogenesis of osteosarcoma

  2019cites this paper
• Canine sarcomas as a surrogate for the human disease

  2018cites this paper
• Knockdown of FBXO 39 inhibits proliferation and promotes apoptosis of human osteosarcoma U ‐ 2 OS cells

  2018cites this paper
• Genetic testing for high-grade osteosarcoma: a guide for future tailored treatments?

  2018cites this paper
• Knockdown of FBXO39 inhibits proliferation and promotes apoptosis of human osteosarcoma U-2OS cells.

  2018cites this paper
• Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors.

  2018cites this paper
• [Pathogenesis and genetics of osteosarcoma : Current concepts and developments].

  2018cites this paper
• CDH4 is a novel determinant of osteosarcoma tumorigenesis and metastasis

  2018cites this paper
• Pathogenese und genetischer Hintergrund des Osteosarkoms

  2018cites this paper
• Screening of candidate key genes associated with human osteosarcoma using bioinformatics analysis

  2017cites this paper
• A novel prognostic model for osteosarcoma using circulating CXCL10 and FLT3LG

  2017cites this paper
• Circulating biomarkers in osteosarcoma: new translational tools for diagnosis and treatment

  2017cites this paper
• Kinome expression profiling of human neuroblastoma tumors identifies potential drug targets for ultra high-risk patients

  2017cites this paper
• Advances in the Treatment of Pediatric Bone Sarcomas.

  2017cites this paper
• OMICS Approach for Identifying Predictive Biomarkers in Osteosarcoma

  2017cites this paper
• Osteosarcoma: From Molecular Biology to Mesenchymal Stem Cells

  2017cites this paper
• Somatic mutations in tumors: their detection, generation mechanisms and implications

  2017cites this paper
• Genome‐wide analysis of somatic copy number alterations and chromosomal breakages in osteosarcoma

  2017cites this paper
• Identification and Validation of DLG2 as a Novel Tumor Suppressor in Osteosarcoma

  2016cites this paper
• The roles and therapeutic potential of cyclin-dependent kinases (CDKs) in sarcoma

  2016cites this paper
• Genetic factors conferring metastasis in osteosarcoma.

  2016cites this paper
• NKD2 a novel marker to study the progression of osteosarcoma development.

  2016cites this paper
• Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies

  2016cites this paper
• Generation of Osteosarcomas from a Combination of Rb Silencing and c‐Myc Overexpression in Human Mesenchymal Stem Cells

  2016cites this paper
• The role of pharmacogenetics in the treatment of osteosarcoma.

  2016cites this paper
• The pharmacogenomics of osteosarcoma

  2016cites this paper
• Potential role of S-adenosylmethionine in osteosarcoma development

  2016cites this paper
• Integrative analysis of microRNA and mRNA expression profiles in osteosarcoma cell lines

  2016cites this paper
• The role of P 2 X 7 R purinoreceptor in osteosarcoma

  2015cites this paper
• CD8+/FOXP3+-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study

  2015cites this paper
• Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.

  2015cites this paper
• Identification and functional analysis of differentially expressed genes related to metastatic osteosarcoma.

  2015influential citation
• Genomic Heterogeneity of Osteosarcoma - Shift from Single Candidates to Functional Modules

  2015influential citation
• Predictive properties of DNA methylation patterns in primary tumor samples for osteosarcoma relapse status

  2015cites this paper
• p53 mediated apoptosis in osteosarcoma MG-63 cells by inhibition of FANCD2 gene expression.

  2015cites this paper
• p 53 mediated apoptosis in osteosarcoma MG-63 cells by inhibition of FANCD 2 gene expression

  2015cites this paper
• Molecular Features of Mesenchymal Tumors of the Breast

  2015cites this paper
• Markers for bone sarcomas

  2015cites this paper
• Stemness markers of osteosarcoma

  2015cites this paper
• Chapter 28 – Cytogenetic and molecular genetic alterations in bone tumors

  2015cites this paper
• Advances in emerging drugs for osteosarcoma

  2015cites this paper
• ROLE OF AMPLIFICATION OF CHROMOSOME 6P12-P21 IN HUMAN OSTEOSARCOMA

  2015cites this paper
• The role of P2X7R purinoreceptor in osteosarcoma

  2015cites this paper
• Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model

  2014cites this paper
• Digital Expression Profiling Identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as Potential Predictive Biomarkers for Neo-Adjuvant Chemotherapy Response in Paediatric Osteosarcoma

  2014cites this paper
• Structuring osteosarcoma knowledge: an osteosarcoma-gene association database based on literature mining and manual annotation

  2014influential citation
• The role of inflammation in sarcoma.

  2014cites this paper
• Epigenetic alterations in osteosarcoma: promising targets

  2014cites this paper
• Proteomics of osteosarcoma

  2014cites this paper
• A New Paradigm to Mitigate Osteosarcoma by Regulation of MicroRNAs and Suppression of the NF-κB Signaling Cascade.

  2014cites this paper
• CURRENT APPROACHES IN THE TREATMENT OF OSTEOSARCOMAS

  2014cites this paper
• Upregulation of the miR-17-92 cluster and its two paraloga in osteosarcoma – reasons and consequences

  2014influential citation
• Genetic and molecular dissection of the role of dissolution and resolution in the maintenance of genomic stability

  2014cites this paper
• A Rb1 promoter variant with reduced activity contributes to osteosarcoma susceptibility in irradiated mice

  2014cites this paper
• The β5/focal adhesion kinase/glycogen synthase kinase 3β integrin pathway in high-grade osteosarcoma: a protein expression profile predictive of response to neoadjuvant chemotherapy.

  2013cites this paper
• Distinct profiles of oxidative stress-related and matrix proteins in adult bone and soft tissue osteosarcoma and desmoid tumors: a proteomics study.

  2013cites this paper
• Perspectives on cancer stem cells in osteosarcoma.

  2013cites this paper
• Treating pediatric osteosarcoma: recent clinical trial evidence

  2013cites this paper
• Genetic Imbalances in Endometriosis Detected by Oligonucleotide-Array Based Comparative Genomic Hybridization

  2013cites this paper
• Genome-wide analyses of sarcoma: implications for future treatment options.

  2013cites this paper
• How MicroRNA and Transcription Factor Co-regulatory Networks Affect Osteosarcoma Cell Proliferation

  2013cites this paper
• Molekulare Charakterisierung von Osteosarkomen

  2013cites this paper
• Genome‐wide analyses on high‐grade osteosarcoma: Making sense of a genomically most unstable tumor

  2013cites this paper
• Secondary Radiation-Induced Bone Tumours Demonstrate a High Degree of Genomic Instability Predictive of a Poor Prognosis

  2012influential citation
• Genetically engineered mouse models and human osteosarcoma

  2012cites this paper
• Histopathology and Molecular Pathology of Bone and Extraskeletal Osteosarcomas

  2012cites this paper
• MicroRNA profiling with correlation to gene expression revealed the oncogenic miR-17-92 cluster to be up-regulated in osteosarcoma.

  2012cites this paper
• Bone Formation Deregulations Are the Oncogenesis Keys in Osteosarcomas

  2012cites this paper
• Relevance of chromosome 13 aberrations in canine tumours

  2012cites this paper
• A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers.

  2012influential citation